What are the current best‑practice guidelines for the acute management of stroke in adults, including both ischemic and hemorrhagic types?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Current Best-Practice Guidelines for Acute Stroke Management

All patients with suspected acute stroke require immediate non-contrast CT imaging to exclude hemorrhage and determine eligibility for reperfusion therapy, with CT angiography added for those presenting within 6 hours to identify large vessel occlusions amenable to endovascular thrombectomy. 1

Immediate Assessment and Imaging

Initial Evaluation

  • Stabilize airway, breathing, and circulation while simultaneously beginning stroke evaluation 2
  • Determine exact time of last known normal (when patient was last symptom-free), as this defines treatment eligibility 2
  • Assess stroke severity using the National Institutes of Health Stroke Scale (NIHSS) to guide treatment decisions 2
  • Complete non-contrast CT within 25 minutes of arrival and interpret within 45 minutes 1, 2

Imaging Protocol

  • For patients presenting within 6 hours: Perform both non-contrast CT and CT angiography (arch-to-vertex) immediately to identify large vessel occlusions eligible for endovascular thrombectomy 1
  • For patients presenting beyond 6 hours: Non-contrast CT alone is sufficient unless advanced imaging is needed for patient selection 1
  • Advanced imaging (CT perfusion, multiphase CTA) may be considered to aid patient selection but must not delay thrombolysis or thrombectomy decisions 1
  • MRI with diffusion-weighted imaging is more sensitive than CT for detecting acute ischemia but should only be used if it does not delay treatment 3, 4, 5

Essential Laboratory Tests

  • Blood glucose (must exclude hypoglycemia <50 mg/dL before thrombolysis) 1
  • Complete blood count with platelet count (must be >100,000/mm³ for thrombolysis) 1
  • PT/INR and aPTT (INR must be ≤1.7 for thrombolysis) 1
  • Electrolytes and renal function 2
  • 12-lead ECG to identify atrial fibrillation or acute coronary syndrome 1, 6

Acute Ischemic Stroke Treatment

Intravenous Thrombolysis (Alteplase/rtPA)

Eligibility Criteria for 0-3 Hour Window: 1

  • Measurable neurologic deficit on NIHSS
  • Age ≥18 years
  • No head trauma or prior stroke in previous 3 months
  • No intracranial hemorrhage on CT
  • Blood pressure <185/110 mmHg
  • Platelet count ≥100,000/mm³
  • INR ≤1.7
  • Blood glucose ≥50 mg/dL
  • No multilobar infarction (>1/3 cerebral hemisphere) on CT

Additional Exclusion Criteria for 3-4.5 Hour Window: 1

  • Age >80 years
  • NIHSS >25
  • Taking oral anticoagulants (regardless of INR)
  • History of both diabetes AND prior stroke

Administration Protocol: 6

  • Dose: 0.9 mg/kg (maximum 90 mg total)
  • Give 10% as IV bolus over 1 minute
  • Give remaining 90% as IV infusion over 60 minutes
  • Target door-to-needle time <60 minutes 6

Blood Pressure Management for Thrombolysis Candidates

Before and during thrombolysis: 1, 6

  • Blood pressure must be lowered to <185/110 mmHg before starting alteplase
  • Maintain blood pressure <180/105 mmHg for 24 hours after alteplase administration
  • Use labetalol 10 mg IV or nicardipine IV infusion (5 mg/h, titrate by 2.5 mg/h every 5-15 minutes, maximum 15 mg/h) 1
  • Avoid precipitous drops in blood pressure 1

Blood Pressure Management for Non-Thrombolysis Candidates

For patients NOT receiving thrombolysis: 1, 6

  • Do NOT routinely treat hypertension in acute ischemic stroke 1
  • Only treat if systolic BP >220 mmHg or diastolic BP >120 mmHg 1
  • Target: reduce blood pressure by 15% (not more than 25%) over first 24 hours 1
  • Avoid rapid or excessive lowering as this may worsen ischemia 1

Endovascular Thrombectomy (EVT)

Indications: 1, 6

  • Large vessel occlusion identified on CT angiography
  • Presentation within 6 hours of symptom onset (may extend to 24 hours with advanced imaging selection)
  • Use validated triage tool (such as ASPECTS) to identify EVT candidates 1
  • Combined IVT plus EVT is preferred over EVT alone when IVT is not contraindicated 1
  • Direct aspiration is suggested over stent retriever as first-line EVT strategy 1

Transfer Protocol: 1

  • Primary stroke centers without EVT capability should complete non-contrast CT, administer IV alteplase if appropriate, then rapidly transfer to comprehensive stroke center for EVT consideration

Post-Treatment Monitoring and Care

Neurological Monitoring

  • Monitor NIHSS every 15 minutes during thrombolysis 7
  • Then hourly for 6 hours 7
  • Then every 2 hours for 18 hours 7
  • Obtain repeat non-contrast CT at 24 hours or sooner if neurological deterioration 7

Blood Pressure Monitoring After Thrombolysis

  • Every 15 minutes for 2 hours from start of rtPA 1
  • Every 30 minutes for next 6 hours 1
  • Every hour for next 16 hours 1

Swallowing Assessment

  • Keep patient NPO until formal swallowing screen completed 1, 7
  • Perform bedside swallowing screen within 24 hours using validated tool 1, 7
  • This should not delay acute treatment decisions 1

Admission and Supportive Care

  • Admit all acute stroke patients to specialized stroke unit with continuous monitoring 7
  • Maintain oxygen saturation >94% 6
  • Treat fever if temperature >38°C (or >37.5°C per some protocols) 6, 7
  • Correct hypoglycemia (<60 mg/dL); maintain glucose 140-180 mg/dL 6, 7
  • Begin venous thromboembolism prophylaxis with intermittent pneumatic compression devices within 24 hours 2, 7
  • Consider subcutaneous heparin or enoxaparin after 24 hours if no hemorrhagic transformation 7

Early Mobilization and Rehabilitation

  • Begin early mobilization within 24 hours if patient stable 2, 7
  • Initiate physical therapy, occupational therapy, and speech therapy consultations within 24 hours 7

Antiplatelet Therapy

  • For patients NOT receiving thrombolysis: Start aspirin 160-325 mg within 24-48 hours 6
  • For patients who received thrombolysis: Delay aspirin for 24 hours and obtain repeat CT to exclude hemorrhage before starting 6, 7

Critical Pitfalls to Avoid

  • Do not delay imaging for laboratory results - CT should be performed immediately upon arrival 1
  • Do not aggressively lower blood pressure in non-thrombolysis candidates - permissive hypertension maintains cerebral perfusion to penumbra 1, 7
  • Do not give oral intake before swallowing assessment - aspiration pneumonia significantly worsens outcomes 1, 7
  • Do not use advanced imaging if it delays thrombolysis - door-to-needle time is critical 1
  • Do not delay mobilization beyond 24 hours unless contraindicated - prolonged immobility increases complications 2, 7

Hemorrhagic Stroke Considerations

For patients with intracranial hemorrhage on initial CT:

  • They are NOT candidates for thrombolysis 1
  • Consult neurology/neurosurgery immediately 1
  • Refer to dedicated intracerebral hemorrhage management guidelines 1
  • Surgical decompression may be indicated for large cerebellar infarctions causing brainstem compression 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Initial Workup and Management for Young Adults with Stroke

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Imaging of acute stroke.

Nature reviews. Neurology, 2010

Research

MR imaging in hyperacute ischemic stroke.

European journal of radiology, 2017

Guideline

Acute Stroke Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Acute Ischemic Stroke Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What are the advantages and disadvantages of Magnetic Resonance Imaging (MRI) compared to Computed Tomography (CT) in diagnosing stroke?
What is the next step in management for a patient with suspected stroke and a normal computed tomography (CT) scan?
What is the next step in management for a patient with suspected cerebellar acute stroke and a false negative Magnetic Resonance Imaging (MRI) result, with a high clinical suspicion remaining?
What is the preferred initial imaging modality for an elderly patient with a history of stroke, considering the presence of comorbidities such as dementia or cardiovascular disease, and assuming no contraindications to Magnetic Resonance Imaging (MRI)?
What other stroke tests should I perform on a patient with suspected stroke?
How should esophageal varices be screened and managed—including primary prophylaxis, acute bleed treatment, and secondary prophylaxis—in an adult with cirrhosis?
Should a woman of reproductive age who is taking oral estradiol for hormone replacement stop the estradiol before beginning gonadotropin‑based controlled ovarian hyperstimulation for IVF, and how many days in advance?
In an adult female on oral estradiol therapy, what are the pharmacokinetic and safety interactions with ADHD stimulant medications (e.g., methylphenidate, mixed amphetamine salts, dexmethylphenidate, lisdexamfetamine)?
In an adult female on oral estradiol and an ADHD stimulant (methylphenidate, mixed amphetamine salts, dexmethylphenidate, or lisdexamfetamine), can chlorthalidone be added safely without significant drug interactions?
What are the indications, dosing regimens, contraindications, and alternatives for leucovorin (folinic acid) when used for methotrexate (MTX) rescue, to reduce toxicity from 5‑fluorouracil (5‑FU) or capecitabine chemotherapy, and to treat folate deficiency?
In a patient with an acute L1 vertebral compression fracture who is taking an oral anticoagulant (e.g., warfarin, dabigatran, apixaban, rivaroxaban, edoxaban), what is the safest initial management of the anticoagulation and need for reversal before any invasive spinal procedure?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.